BLUE STAR:

BLUE STAR: CO SAYS WITH RISING INPUT COSTS AND VOLATILE EXCHANGE RATES, THERE WILL BE CHALLENGES IN MANAGING THE MARGINS. FURTHER, THE ONGOING MIDDLE EAST CRISIS CAN LEAD TO SUPPLY CHAIN DISRUPTIONS AND ALSO DAMPEN GROWTH. CO SAYS REGULATORY POLICY FRAMEWORK FOR THE MED-TECH SOLUTIONS BUSINESS STILL REMAINS UNCLEAR, CONSEQUENTLY THE BUSINESS HAS SLOWED DOWN.